FWI
GILD icon

Facet Wealth Inc’s Gilead Sciences GILD Stock Holding History

Facet Wealth Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$354K Sell
2,804
-46
-2% -$6.06K 0.01% 276
2026
Q1 		$397K Buy
2,850
+591
+26% +$82.8K 0.01% 204
2025
Q4 		$316K Buy
+2,259
New +$275K 0.01% 216

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Facet Wealth Inc's GILD Position: Q2 2026 in Review

Facet Wealth Inc reduced its Gilead Sciences (GILD) stake by 1.6% in Q2 2026, selling an estimated $6.06K and leaving 2,804 shares worth $354K. The position accounts for 0.01% of the portfolio, ranked #276.

Facet Wealth Inc first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $397K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Facet Wealth Inc held 2,804 shares of Gilead Sciences worth $354K as of Q2 2026.
  • Facet Wealth Inc sold 46 Gilead Sciences shares in Q2 2026, an estimated $6.06K.
  • Gilead Sciences made up 0.01% of Facet Wealth Inc's portfolio in Q2 2026, its #276 holding.
  • Facet Wealth Inc first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Facet Wealth Inc's Gilead Sciences position peaked at $397K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Facet Wealth Inc's 13F filing for Q2 2026, filed 27 Jul 2026.